CRS Clinical Research Services Appoints Catherine Canales as Chief Commercial Officer

CRS Clinical Research Services Management GmbH has announced the appointment of Catherine Canales as its new Chief Commercial Officer (CCO), effective April 10, 2024. This move aims to drive the company’s strategic development and bolster its international growth. Catherine Canales joins the CRS leadership team with a strong emphasis on enhancing client satisfaction and delivering positive client experiences.

Dr. Elisabeth Lackner, CEO of CRS, expressed enthusiasm about Canales joining the team, highlighting her forward-thinking approach and collaborative leadership style as key to adapting in the dynamic field of clinical research. Catherine Canales, with over two decades of experience in the clinical research services industry, brings a rich background in business development, growth strategy, and strategic marketing. Her previous roles include positions at Labcorp Central Laboratory Services and Premier Research, where she led significant business development, marketing, and sales efforts.

CRS, established in 2006, stands as a leading early-phase Contract Research Organization (CRO) specializing in a range of therapeutic areas. With Catherine Canales at the helm of commercial strategy, CRS is set to further its commitment to excellence in service, driving success and innovation in clinical research on a global scale.